The FBX14 antibody is a tool used in immunodetection for the protein F-box and leucine-rich repeat protein 14 (FBXL14). This protein is involved in various cellular processes and is widely expressed across different tissue types. The FBXL14 protein itself is a member of the F-box family, which plays a role in the ubiquitin-proteasome pathway, crucial for protein degradation and cellular regulation.
FBX14 antibodies are designed to target the FBXL14 protein, which has a reported length of 418 amino acid residues and a mass of approximately 45.9 kDa. These antibodies are commonly used in research applications such as Western Blotting (WB), Enzyme-Linked Immunosorbent Assay (ELISA), and Immunohistochemistry (IHC). They are available in various forms, including unconjugated and conjugated versions, depending on the specific application requirements.
Application | Reactivity | Conjugate/Tag |
---|---|---|
Western Blot (WB) | Human, Mouse, Rat | Unconjugated |
Enzyme-Linked Immunosorbent Assay (ELISA) | Human, Mouse, Rat | Unconjugated |
Immunohistochemistry (IHC) | Human, Mouse, Rat | Unconjugated |
FBXL14 antibodies are utilized in studying the role of FBXL14 in cellular processes. The protein is known for its involvement in the regulation of various biological pathways, and its expression is observed in multiple tissue types. In research settings, these antibodies help in understanding the protein's function and its potential implications in disease models.
Supplier | Product Description | Price |
---|---|---|
Fine Biotech Co., Ltd. | FBXL14 antibody, unconjugated | $240.00 |
GeneTex | Anti-FBXL14 antibody, unconjugated | $399.00 |
United States Biological | Rabbit Anti-FBXL14, CT Antibody, unconjugated | $529.00 |
- Biocompare. (2008). Anti-FBXL14 Antibody Products.
- Biocompare. (2008). FBXL14 Antibody Products.
- PMC. (2011). Development of an Fn14 agonistic antibody as an anti-tumor agent. (Note: While this reference does not directly relate to FBX14, it provides context on the broader use of antibodies in research and therapy.)
FBX14 is an F-box protein found in Arabidopsis thaliana (Mouse-ear cress) that plays a role in plant protein degradation pathways through the ubiquitin-proteasome system. F-box proteins generally function as part of SCF (Skp1-Cullin-F-box) complexes that target specific proteins for ubiquitination and subsequent degradation. In plants, F-box proteins are particularly numerous and diverse, with Arabidopsis containing over 700 F-box genes, suggesting their importance in plant-specific biological processes. FBX14 specifically may be involved in plant development, stress responses, or hormone signaling pathways, making it a valuable target for researchers studying plant molecular biology. Understanding FBX14 function can provide insights into plant regulatory mechanisms and potentially inform agricultural applications.
Based on the available information, there is a polyclonal FBX14 antibody (CSB-PA840425XA01DOA) produced using recombinant Arabidopsis thaliana FBX14 protein as the immunogen and raised in rabbits . This antibody has been tested for applications including ELISA and Western blot, specifically for detecting FBX14 in Arabidopsis thaliana samples . The antibody is provided in liquid form, stored in a buffer containing 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as a preservative . This polyclonal antibody has been affinity-purified against the antigen to enhance specificity for experimental applications. While specific information about other FBX14 antibodies is limited in the current literature, researchers should verify current options when planning experiments to ensure availability of appropriate tools for their specific research needs.
According to the product information, FBX14 antibody should be stored at -20°C or -80°C upon receipt to maintain its stability and effectiveness . Researchers should avoid repeated freeze-thaw cycles as these can degrade antibody quality and reduce binding efficiency over time. When working with the antibody, it should be kept on ice or at 4°C during experiments to minimize degradation. For long-term storage planning, it's advisable to aliquot the antibody into smaller volumes upon receipt to minimize the number of freeze-thaw cycles. The antibody is formulated in a buffer containing glycerol (50%), which helps prevent complete freezing and reduces damage during storage . Always ensure proper labeling of antibody aliquots with relevant information including date of receipt, lot number, and dilution information to maintain experimental reproducibility.
For Western blotting applications with FBX14 antibody, researchers should begin with sample preparation by extracting proteins from Arabidopsis thaliana tissues using an appropriate lysis buffer that preserves protein integrity. Based on general antibody protocols, a recommended dilution range would be 1:500 to 1:2000 for primary antibody incubation, though optimization may be necessary for specific experimental conditions. Blocking should be performed with 5% non-fat dry milk or bovine serum albumin (BSA) in TBST to minimize background signals. Incubation with the primary antibody (FBX14) should be conducted overnight at 4°C with gentle agitation to ensure optimal binding. Following primary antibody incubation, membranes should be washed thoroughly with TBST (at least 3 washes of 5-10 minutes each) before adding an appropriate HRP-conjugated secondary antibody (anti-rabbit IgG) at a dilution of approximately 1:5000 to 1:10000. Signal detection can be performed using enhanced chemiluminescence (ECL) reagents, with exposure times determined empirically based on signal strength.
Parameter | Recommended Condition | Notes |
---|---|---|
Primary Antibody Dilution | 1:500 to 1:2000 | Optimize based on specific lot and application |
Blocking Solution | 5% non-fat milk or BSA in TBST | BSA may provide lower background for some applications |
Primary Antibody Incubation | Overnight at 4°C | Gentle agitation recommended |
Washing | 3 × 10 minutes with TBST | Thorough washing critical for reducing background |
Secondary Antibody | Anti-rabbit IgG-HRP at 1:5000-1:10000 | Select based on detection system |
Detection Method | Enhanced chemiluminescence (ECL) | Exposure time determined empirically |
Expected Band Size | Based on FBX14 molecular weight | Verify against positive control |
When conducting experiments with FBX14 antibody, several controls should be incorporated to ensure result validity and reliable interpretation. A positive control consisting of Arabidopsis thaliana wild-type tissue or recombinant FBX14 protein should be included to confirm antibody functionality and establish the correct band size. A negative control using FBX14 knockout or knockdown plant lines would provide validation of antibody specificity by demonstrating reduced or absent signal. Additionally, a secondary antibody-only control (omitting primary antibody) helps assess non-specific binding of the secondary antibody and establishes background signal levels. For more stringent validation, a blocking peptide competition assay can be performed, where pre-incubation of the antibody with excess FBX14 immunogenic peptide should abolish specific signals if the antibody is truly specific. When performing immunohistochemistry or immunofluorescence, additional controls should include omission of primary antibody and use of pre-immune serum to evaluate background and non-specific staining patterns.
FBX14 antibody can be utilized in co-immunoprecipitation (Co-IP) experiments to identify and characterize protein-protein interactions involving FBX14 in plant systems. For this application, plant tissue lysates can be incubated with FBX14 antibody coupled to protein A/G beads, allowing precipitation of FBX14 along with its interacting partners. The precipitated complexes can then be analyzed by mass spectrometry or Western blotting to identify the components. For verification of specific interactions, researchers can perform reciprocal Co-IPs using antibodies against suspected interaction partners. Additionally, proximity ligation assays (PLA) using FBX14 antibody paired with antibodies against potential interacting proteins can provide in situ visualization of protein complexes in plant cells with high specificity and sensitivity. When studying dynamic interactions, researchers might consider combining FBX14 immunoprecipitation with crosslinking approaches to capture transient interactions, particularly important for F-box proteins which often have dynamic interactions with their substrates during the ubiquitination process. These methods collectively provide powerful tools for elucidating the functional networks and mechanisms through which FBX14 operates in plant cellular processes.
Validating FBX14 antibody specificity is crucial for ensuring reliable research outcomes, particularly for less characterized antibodies. Western blot analysis using both wild-type and FBX14 knockout/knockdown plant lines represents the gold standard for validation, with the appearance of a specific band at the expected molecular weight in wild-type samples and reduced or absent signal in knockout samples confirming specificity. Mass spectrometry analysis of immunoprecipitated proteins can provide unbiased confirmation of antibody specificity by identifying peptides specific to FBX14. Researchers should also consider heterologous expression systems, where FBX14 can be expressed with epitope tags in systems like E. coli or plant protoplasts, allowing parallel detection with both the FBX14 antibody and tag-specific antibodies to confirm target recognition. Peptide competition assays provide another validation approach, where pre-incubation of the antibody with the immunizing peptide should block specific binding if the antibody is truly target-specific. For applications beyond Western blotting, such as immunohistochemistry or immunofluorescence, additional validation steps including signal localization consistent with known FBX14 distribution patterns should be performed to ensure application-specific reliability.
As an antibody targeting an F-box protein involved in the ubiquitin-proteasome system, FBX14 antibody can be instrumental in studying protein degradation pathways in plants. Researchers can use the antibody in pulse-chase experiments combined with immunoprecipitation to track the turnover rates of FBX14 and its substrate proteins under various conditions or treatments. Cycloheximide chase assays utilizing FBX14 antibody for detection can reveal the half-life of FBX14 itself and how its stability may be regulated under different physiological conditions or stress responses. To identify specific substrates of FBX14-containing SCF complexes, researchers can employ strategies combining proteasome inhibitors (such as MG132) with FBX14 immunoprecipitation followed by mass spectrometry analysis, which can capture stabilized substrate proteins that would otherwise be rapidly degraded. Immunofluorescence approaches using FBX14 antibody can provide spatial information about where in the cell these degradation processes are occurring, potentially revealing compartment-specific roles for FBX14-mediated protein turnover. These approaches collectively enable detailed characterization of the regulatory mechanisms governing protein homeostasis in plant systems and the specific contribution of FBX14 to these essential cellular processes.
Researchers working with FBX14 antibody may encounter several common issues that can be systematically addressed through optimization strategies. High background signal in Western blots or immunostaining can result from insufficient blocking or excessive antibody concentration, and can be mitigated by increasing blocking time (to 2-3 hours), using alternative blocking reagents (switching between milk and BSA), or further diluting the primary antibody. Weak or absent signal might stem from protein degradation during sample preparation, inefficient protein transfer during Western blotting, or suboptimal antibody dilution, requiring adjustments to extraction protocols (adding more protease inhibitors), optimizing transfer conditions, or testing more concentrated antibody solutions. Multiple bands or non-specific signals may indicate cross-reactivity, which can be addressed by increasing the stringency of washing steps, optimizing antibody dilution, or using alternative extraction buffers to reduce interfering proteins. Batch-to-batch variation in antibody performance can significantly impact experimental reproducibility, necessitating careful validation of each new lot and maintenance of detailed records of optimal conditions for each batch. For particularly challenging applications, consideration of alternative detection methods such as more sensitive chemiluminescent substrates or signal amplification systems may be necessary to achieve desired results.
Issue | Possible Causes | Solutions |
---|---|---|
High background | Insufficient blocking, antibody concentration too high | Increase blocking time/concentration, dilute antibody further |
Weak/no signal | Protein degradation, inefficient transfer, low antibody concentration | Add protease inhibitors, optimize transfer, increase antibody concentration |
Multiple bands | Cross-reactivity, protein degradation | Increase wash stringency, add protease inhibitors, validate antibody |
Inconsistent results | Batch variation, sample handling | Validate each new antibody lot, standardize protocols |
Non-specific binding | Secondary antibody issues, insufficient blocking | Test secondary antibody alone, optimize blocking |
Optimizing FBX14 antibody performance across different plant tissues and developmental stages requires careful consideration of tissue-specific factors that may affect antibody binding and specificity. For tissues with high levels of phenolic compounds or secondary metabolites (such as mature leaves or roots), modified extraction buffers containing polyvinylpyrrolidone (PVP) or polyvinylpolypyrrolidone (PVPP) can help prevent interference with antibody binding. Tissues with different protein expression levels may require adjusted antibody dilutions; for tissues with expected low FBX14 expression, more concentrated antibody solutions and extended incubation times may be necessary. When working with difficult-to-extract tissues like seeds or siliques, researchers should consider enhanced mechanical disruption methods (such as bead-beating) combined with more stringent extraction buffers to ensure sufficient protein release for subsequent detection. For developmental studies, it's important to establish a baseline of FBX14 expression patterns across different stages using techniques like qRT-PCR alongside antibody-based detection to properly interpret changes in protein levels. Particularly for quantitative comparisons across developmental stages or tissues, researchers should establish and use consistent internal loading controls appropriate for the specific tissues being compared to ensure accurate normalization and interpretation of results.